KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Edwards Lifesciences (EW) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to 0.12%.

  • Edwards Lifesciences' Return on Capital Employed fell 300.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.14% for FY2024, which is 300.0% down from last year.
  • According to the latest figures from Q3 2025, Edwards Lifesciences' Return on Capital Employed is 0.12%, which was down 300.0% from 0.12% recorded in Q2 2025.
  • Edwards Lifesciences' Return on Capital Employed's 5-year high stood at 0.25% during Q2 2021, with a 5-year trough of 0.12% in Q4 2024.
  • Over the past 5 years, Edwards Lifesciences' median Return on Capital Employed value was 0.16% (recorded in 2024), while the average stood at 0.18%.
  • Over the last 5 years, Edwards Lifesciences' Return on Capital Employed had its largest YoY gain of 1000bps in 2021, and its largest YoY loss of -800bps in 2021.
  • Edwards Lifesciences' Return on Capital Employed (Quarter) stood at 0.23% in 2021, then fell by -13bps to 0.2% in 2022, then dropped by -17bps to 0.17% in 2023, then dropped by -28bps to 0.12% in 2024, then increased by 1bps to 0.12% in 2025.
  • Its last three reported values are 0.12% in Q3 2025, 0.12% for Q2 2025, and 0.12% during Q1 2025.